Recurrent urinary tract infections in women. Virulence of pathogens and host reaction;Rezidivierende harnweginfektionen der frau. Erregervirulenz und wirtsreaktion

Urologe - Ausgabe A

Volumn 45, Issue 4, 2006, Pages 412-420

  Oelschlaeger, T ^a   Funfstuck R ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Sophien und Hufeland Klinikum Weimar   (Germany)

Author keywords

Bacterial invasion; Host factors; Reservoir formation; Urine composition; Virulence factors

Indexed keywords

ANTIBIOTIC AGENT; ESTROGEN;

ANAMNESIS; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL FLORA; BLADDER OBSTRUCTION; CYSTITIS; CYSTOCELE; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; ENTEROCOCCUS; ESCHERICHIA COLI; ESTROGEN DEFICIENCY; FEMALE; HUMAN; IMMUNE STATUS; KLEBSIELLA; PATHOGENESIS; PERSONAL HYGIENE; PREMENOPAUSE; PROTEUS; PSEUDOMONAS; SEXUAL INTERCOURSE; STAPHYLOCOCCUS; STREPTOCOCCUS; TEST STRIP; URINALYSIS; URINARY TRACT INFECTION; URINE INCONTINENCE;

ANIMALS; ANTI-INFECTIVE AGENTS, URINARY; ANTIBODIES, BACTERIAL; BACTERIAL ADHESION; CREATININE; EPITHELIUM; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; IMMUNE TOLERANCE; MICE; RECURRENCE; RISK FACTORS; UREA; URINARY TRACT INFECTIONS; VIRULENCE;

EID: 33646244475     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-006-1020-z     Document Type: Article

References (30)

1. Anderson M, Bollinger D, Hagler A, Hartwell H, Rivers B, Ward K, Steck TR (2004) Viable but nonculturable bacteria are present in mouse and human urine specimens. J Clin Microbiol 42: 753-758
2. Arthur M, Johnson CE, Rubin RH et al. (1989) Molecular epidemiology of adhesin and hemolysin virulence factors among uropathogenic Escherichia coli. Infect Immun 57: 303-313
3. Bates JM, Raffi HM, Prasadan K (2004) Tamm-Horsefall protein knockout mice are more prone to urinary tract infection: rapid communication. Kidney Int 65: 791-797
4. Bouckaert J, Berglund J, Schembri M et al. (2005) Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin. Mol Microbiol 55: 441-455
5. Bower JM, Eto DS, Mulvey MA (2005) Covert operations of uropathogenic Escherichia coli within the urinary tract. Traffic 6: 18-31
6. Chambers ST, Lever M (1996) Betaines and urinary tract infections. Nephron 74: 1-10
7. Fasth A, Hanson LA, Jodal U, Peterson H (1979) Autoantibodies to Tamm-Horsfall protein association with urinary tract infections in girls. J Pediatr 95: 50-54
8. Finer G, Landan D (2004) Pathogenesis of urinary tract infections with normal female antomy. Lancet Infect Dis 4: 631-635
9. Foxman B, Zhang L, Tallman P, Palin K, Rode C, Bloch C, Gillespie B, Marrs CF (1995) Virulence characteristics of Escherichia coli causing first urinary tract infection predict risk of second infection. J Infect Dis 172: 1536-1541
10. Fünfstück R, Smith JW, Tschäpe H, Stein G (1997) Pathogenetic aspects of uncomplicated urinary tract infection: recent advances. Clin Nephrol 47: 13-18
11. Fünfstück R, Stein G (2002) Harnwegsinfektionen bei Diabetes mellitus. Spectr Diabetes 4: 7-13
12. Geerlings SE, Brouwer EC, Gaastra W, Verhoef J, Hoepelmann AJM (1999) Effects of glucose and pH on uropathogenic and non-uropathogenic Escherichia coli studies with urine from diabetic and non-diabetic individuals. J Med Microbiol 48:535-539
13. Goluszko P, Moseley SL, Truong LD et al. (1997) Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae. J Clin Invest 99: 1662-1672
14. Goluszko P, Goluszko E, Nowicki G, Nowicki S, Popov V, Wang H-Q (2005) Vaccination with purified Dr fimbriae reduces mortality associated with chronic urinary tract infection due to Escherichia coli bearing Dr adhesion. Infect Immun 73: 627-631
15. Hiratuska T, Nakazato M, Shimizu A et al. (2000) Structural analysis of human β-defensin-1 and its significance in urinary tract infection. Nephron 85: 35-4
16. Johnson JR, Johnson CE, Maslow JN (1999) Clinical and bacteriological correlates of the papG alleles among Escherichia coli strains from children with acute cystitis. Pediatr Infect Dis J 18: 446-451
17. Johnson JR, O'Bryan TT, Delavari P, Kuskowski M, Stapleton A, Carlino U, Russo TA (2001) Clonal relationships and extended virulence genotypes among Escherichia coli isolates from women with a first or recurrent episode of cystitis. J Infect Dis 183: 1508-1517
18. Karkkainen UM, Ikaheimo R, Katila MJ, Siitonen A (2000) Recurrence of urinary tract infections in adult patients with community-acquired pyelonephritis caused by E. coli: a 1-year follow-up. Scand J Infect Dis 32: 495-499
19. Kreft B, Jabs WJ, Laskay T (2002) Polarized expression of Tamm-Horesefall protein by renal tubular epithelial cells activates human granulocytes. Infect Immun 70: 2650-2656
20. Kokot F, Dulawa J (2000) Tamm-Horsefall-Protein updated. Nephron 85: 97-102
21. Kunin CM (1997) Urinary tract infection. Williams & Williams, Baltimore, pp 337-338
22. Langermann S, Mollby R, Burlein JE et al. (2000) Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli. J Infect Dis 181: 774-778
23. Oelschlaeger TA, Dobrindt U, Hacker J (2002) Pathogenicity islands of uropathogenic E. coli and the evolution of virulence. Int J Antimicrob Agents 19: 517-521
24. Oelschlaeger TA, Friedrich A (2002) Antibiotika gegen Erreger von Harnwegsinfektionen: extra- und intrazelluläre Wirksamkeit. Gynäkol Nachricht 3: 10
25. Rakita RM (1998) Intracellular activity, potential clinical uses of antibiotics. ASM News 64: 570-575
26. Reinhart HH, Obedeann N, Robinson N (1990) Urinary excretion of Tamm-Horsfall-protein in woman with recurrent urinary tract infection. J Urol 144: 1185-1187
27. Säemann MD, Weichhart T, Zeyda M (2005) Tamm-Horsefall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism. J Clin Invest 115: 468-475
28. Schilling JD, Lorenz RG, Hultgren SJ (2002) Effect of trimethoprim-sulamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli. Infect Immun 70: 7042-7049
29. Schnapp D, Reid CJ, Harris A (1998) Localisation of expression of human beta defensin-1 in the pancreas and kidney. J Pathol 189: 99-103
30. Serafini-Cessi F, Malagonini N, Cavallone D (2003) Tamm-Horsfall Glykoprotein: Biology and clinical relevance. Am J Kid Dis 42: 658-676